Portfolio

Top Stocks

Quarterly Top 10 Holdings for Quarter End 30-Jun-2021

as of 30-Jun-2021

The Valens Company Inc. 9.54%
Tilray, Inc. Com 8.84%
Sundial Growers Inc. 6.07%
Power REIT (MD) 5.96%
GrowGeneration Corp. 5.75%
Gilead Sciences Inc. 5.58%
Aurora Cannabis Inc. 5.28%
Canopy Growth Corporation 4.82%
Amplify Seymour Cannabis ETF 4.78%
Innovative Industrial Properties, Inc. 4.78%

Top Portfolio Holdings for Quarter End 30-Jun-2021

as of 30-Jun-2021

1. The Valens Company Inc. (VLNCF)
A developer and manufacturer of cannabinoid-based products. The company's extraction methods are CO2, ethanol, hydrocarbon, solvent-less, and terpene extraction. Its products are tinctures, capsules, beverages, and vape cartridges among others. Its reportable segments are cannabis operations, analytical testing, and corporate. The
2. Tilray, Inc. Com (TLRY)
Cultivates and sells medical and recreational cannabis through a portfolio of brands that include Canaca, Dubon, and Manitoba Harvest. The bulk of Tilray's sales are in Canada, but the company also sells CBD Products in the U.S. and exports medical cannabis globally from its production facilities in Canada and Portugal.
3. Sundial Growers Inc. (SNDL)
Is engaged in producing and marketing of cannabis for the adult-use market. Some of its products are Lemon Riot, Daydream, Zen Berry, Twilight, Tropical Bliss, Pillow Talk, Citrus Punch, and others. The company's primary focus is on producing and distributing inhalable products and brands (flower, pre-rolls, and vapes). It operates in two
4. Power REIT (PW)
A real-estate investment trust focused on providing long-term real estate solutions to energy and transportation infrastructure asset owners and developers.
5. GrowGeneration Corp. (GRWG)
GrowGeneration Corp operates hydroponic and organic specialty gardening retail outlets in the United States. It sells products including organic nutrients and soil, advanced lighting technology, hydroponic and aquaponics equipment and other products.
6. Gilead Sciences Inc. (GILD)
Develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer.
7. Aurora Cannabis Inc. (ACB)
Cultivates and sells medicinal and recreational cannabis through a portfolio of brands.
8. Canopy Growth Corporation (CGC)
Cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands.
9. Amplify Seymour Cannabis ETF (CNBS)
The fund will invest at least 80% of its net assets (including investment borrowings) in the securities of companies that derive 50% or more of their revenue from the cannabis and hemp ecosystem.
10. Innovative Industrial Properties, Inc. (IIPR)
The Company is engaged in the acquisition, ownership and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities